Hôpital Saint Louis APHP

Paris 75010

2 studies enrolling now · 7 studies all time

What they study most

Advanced Breast Cancer, Advanced Head and Neck Squamous Cell Carcinoma, Advanced Melanoma, Advanced Solid Tumors, Cutaneous Melanoma, Diffuse Large B-cell Lymphoma (DLBCL), Epitheliod Sarcoma (ES), Follicular Lymphoma (FL), HSV Infection, Merkel Cell Carcinoma, Mesothelioma, Microsatellite Instability-High (MSI-H)

Studies at this site

• VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3] — Recruiting now
• Study of TL-895 Combined With Ruxolitinib in JAKi Treatment-Naïve MF Subjects and Subjects With MF Who Have a Suboptimal Response to Ruxolitinib — Recruiting now
• Trial on Efficacy and Safety of Pritelivir Tablets for Treatment of Acyclovir-resistant Mucocutaneous HSV (Herpes Simplex Virus) Infections in Immunocompromised Subjects — Completed
• Study of RP1 Monotherapy and RP1 in Combination With Nivolumab (IGNYTE) — Running, not enrolling
• A Study to Evaluate the Safety and Efficacy of CyPep-1 in Combination With Pembrolizumab for the Treatment of Advanced or Metastatic Cancers — Completed
• A Study to Assess Long-term Safety of Tazemetostat in Adult Participants of All Ages With Any Disease Treated With Tazemetostat in a Previous Clinical Study — Completed
• Navtemadlin (KRT-232) With or Without Anti-PD-1/Anti-PD-L1 for the Treatment of Patients With Merkel Cell Carcinoma — Status unconfirmed